These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34103635)

  • 1. PB01 suppresses radio-resistance by regulating ATR signaling in human non-small-cell lung cancer cells.
    Kim TW; Hong DW; Hong SH
    Sci Rep; 2021 Jun; 11(1):12093. PubMed ID: 34103635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
    Kim TW; Hong DW; Park JW; Hong SH
    Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC).
    Dunne VL; Ghita-Pettigrew M; Redmond KM; Small DM; Weldon S; Taggart CC; Prise KM; Hanna GG; Butterworth KT
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
    Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
    J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial-mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway.
    Zou K; Li Z; Zhang Y; Mu L; Chen M; Wang R; Deng W; Zou L; Liu J
    Aging (Albany NY); 2020 Dec; 13(2):2575-2592. PubMed ID: 33316778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung Cancer.
    Feng J; Zhang S; Wu K; Wang B; Wong JY; Jiang H; Xu R; Ying L; Huang H; Zheng X; Chen X; Ma S
    Mol Cancer Ther; 2016 May; 15(5):842-53. PubMed ID: 26839308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure.
    Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel PPARɣ ligand, PPZ023, overcomes radioresistance via ER stress and cell death in human non-small-cell lung cancer cells.
    Kim TW; Hong DW; Kang CM; Hong SH
    Exp Mol Med; 2020 Oct; 52(10):1730-1743. PubMed ID: 33046822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
    Vanajothi R; Srinivasan P
    J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated.
    Park SY; Kim YM; Pyo H
    Mol Cancer; 2010 Aug; 9():222. PubMed ID: 20731837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach.
    Pan ST; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():937-68. PubMed ID: 25733813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
    Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
    Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells.
    He Y; Xie H; Yu P; Jiang S; Wei L
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1049-1059. PubMed ID: 30302523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-3 knockout attenuates radiation-induced tumor repopulation via impairing the ATM/p53/Cox-2/PGE
    Zhao M; Wang Y; Zhao Y; He S; Zhao R; Song Y; Cheng J; Gong Y; Xie J; Wang Y; Hu B; Tian L; Huang Q
    Aging (Albany NY); 2020 Nov; 12(21):21758-21776. PubMed ID: 33180744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
    Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
    Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells.
    Dong JC; Gao H; Zuo SY; Zhang HQ; Zhao G; Sun SL; Han HL; Jin LL; Shao LH; Wei W; Jin SZ
    J Cell Mol Med; 2015 Sep; 19(9):2286-95. PubMed ID: 26147006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
    Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway.
    Huang WC; Kuo KT; Wang CH; Yeh CT; Wang Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):180. PubMed ID: 31036057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.